OPTIMER PHARMACEUTICALS INC 4
4 · OPTIMER PHARMACEUTICALS INC · Filed Feb 23, 2009
Insider Transaction Report
Form 4
Frapaise Francois-Xavier
SVP, Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2009-02-19+120,000→ 120,000 totalExercise: $10.85Exp: 2009-02-19→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on the year year anniversary of the vesting commencement date, and 1/48 of the total shares shall vest each month thereafter, subject to optionee continuing to be a service provider on each such date.